» Articles » PMID: 26899835

Mini Mental State Examination and Logical Memory Scores for Entry into Alzheimer's Disease Trials

Overview
Date 2016 Feb 23
PMID 26899835
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Specific cutoff scores on the Mini Mental State Examination (MMSE) and the Logical Memory (LM) test are used to determine inclusion in Alzheimer's disease (AD) clinical trials and diagnostic studies. These screening measures have known psychometric limitations, but no study has examined the diagnostic accuracy of the cutoff scores used to determine entry into AD clinical trials and diagnostic studies.

Methods: ClinicalTrials.gov entries were reviewed for phases II and III active and recruiting AD studies using the MMSE and LM for inclusion. The diagnostic accuracy of MMSE and LM-II cutoffs used in AD trials and diagnostic studies was examined using 23,438 subjects with normal cognition, mild cognitive impairment (MCI), and AD dementia derived from the National Alzheimer's Coordinating Center database.

Results: MMSE and LM cutoffs used in current AD clinical trials and diagnostic studies had limited diagnostic accuracy, particularly for distinguishing between normal cognition and MCI, and MCI from AD dementia. The MMSE poorly discriminated dementia stage.

Conclusions: The MMSE and LM may result in inappropriate subject enrollment in large-scale, multicenter studies designed to develop therapeutics and diagnostic methods for AD.

Citing Articles

The role of sleep in Alzheimer's disease: a mini review.

Pathmanathan J, Westover M, Sivakumaran S, Donoghue J, Puryear C Front Neurosci. 2025; 19:1428733.

PMID: 39975973 PMC: 11835855. DOI: 10.3389/fnins.2025.1428733.


Incidence and Prevalence of Dementia: A 2015-2020 Population-Based Study in the Campania Region of Italy.

Affinito G, Salerno V, Di Gennaro M, Scafa L, Russo A, Fumo M Neuroepidemiology. 2024; 58(6):492-503.

PMID: 38657587 PMC: 11633899. DOI: 10.1159/000539031.


Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [F]BCPP-EF PET study.

Shatalina E, Whitehurst T, Onwordi E, Gilbert B, Rizzo G, Whittington A EJNMMI Res. 2024; 14(1):41.

PMID: 38632153 PMC: 11024075. DOI: 10.1186/s13550-024-01099-1.


Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.

Podger L, Stewart W, Serrano D, Lipton R, Gomez-Ulloa D, Ayasse N J Alzheimers Dis. 2024; 98(3):1079-1094.

PMID: 38489186 PMC: 11091599. DOI: 10.3233/JAD-231197.


Prevalence, cognitive characteristics, and influencing factors of amnestic mild cognitive impairment among older adults residing in an urban community in Chengdu, China.

Rao S, Cai Y, Zhong Z, Gou T, Wang Y, Liao S Front Neurol. 2024; 15:1336385.

PMID: 38356893 PMC: 10864602. DOI: 10.3389/fneur.2024.1336385.


References
1.
Tremont G, Halpert S, Javorsky D, Stern R . Differential impact of executive dysfunction on verbal list learning and story recall. Clin Neuropsychol. 2001; 14(3):295-302. DOI: 10.1076/1385-4046(200008)14:3;1-P;FT295. View

2.
Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

3.
Johnson D, Storandt M, Balota D . Discourse analysis of logical memory recall in normal aging and in dementia of the Alzheimer type. Neuropsychology. 2003; 17(1):82-92. View

4.
Tombaugh T, McIntyre N . The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992; 40(9):922-35. DOI: 10.1111/j.1532-5415.1992.tb01992.x. View

5.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L . Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004; 256(3):240-6. DOI: 10.1111/j.1365-2796.2004.01380.x. View